Sherie A. Dowsett, Ph.D. - Publications

2001 Indiana University, Bloomington, Bloomington, IN, United States 
Dentistry, Microbiology Biology, Public Health

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Cummings J, Aisen PS, DuBois B, Frölich L, Jack CR, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P. Drug development in Alzheimer's disease: the path to 2025. Alzheimer's Research & Therapy. 8: 39. PMID 27646601 DOI: 10.1186/s13195-016-0207-9  1
2015 Brock G, Heiselman D, Maggi M, Kim SW, Rodríguez Vallejo JM, Behre HM, McGettigan J, Dowsett SA, Hayes RP, Knorr J, Ni X, Kinchen K. Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo-Controlled Study. The Journal of Urology. PMID 26498057 DOI: 10.1016/j.juro.2015.10.083  1
2015 Crawford ED, Poage W, Nyhuis A, Price DA, Dowsett SA, Gelwicks S, Muram D. Measurement of testosterone: how important is a morning blood draw? Current Medical Research and Opinion. 31: 1911-4. PMID 26360789 DOI: 10.1185/03007995.2015.1082994  1
2015 Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimer's Research & Therapy. 7: 43. PMID 26120369 DOI: 10.1186/s13195-015-0127-0  1
2015 Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 7: 39. PMID 26120368 DOI: 10.1186/s13195-015-0122-5  1
2015 Crawford ED, Poage W, Nyhuis A, Price DA, Dowsett SA, Muram D. Effects of Testosterone Level on Lower Urinary Tract Symptoms. American Journal of Men's Health. PMID 26077271 DOI: 10.1177/1557988315590655  1
2015 Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients Alzheimer's and Dementia. DOI: 10.1016/j.jalz.2015.06.1893  1
2014 Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC. Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings. Current Medical Research and Opinion. 30: 2021-32. PMID 24983746 DOI: 10.1185/03007995.2014.939167  1
2013 Hoog SL, Cheng Y, Elpers J, Dowsett SA. Duloxetine and pregnancy outcomes: safety surveillance findings. International Journal of Medical Sciences. 10: 413-9. PMID 23471302 DOI: 10.7150/ijms.5213  1
2012 Powles TJ, Diem SJ, Fabian CJ, Neven P, Wickerham DL, Cox DA, Muram D, Agnusdei D, Dowsett SA, Amewou-Atisso M, Cummings SR. Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene. Breast Cancer Research and Treatment. 134: 299-306. PMID 22484799 DOI: 10.1007/s10549-012-2041-5  1
2012 Goldstein SR, Bhattoa HP, Neven P, Cox DA, Dowsett SA, Alam J, Sipos A, Muram D. Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Menopause (New York, N.Y.). 19: 41-7. PMID 21993078 DOI: 10.1097/gme.0b013e318223bbf4  1
2012 Kendler DL, Palacios S, Cox DA, Stock J, Alam J, Dowsett SA, Zanchetta J. Arzoxifene versus raloxifene: Effect on bone and safety parameters in postmenopausal women with osteoporosis Osteoporosis International. 23: 1091-1101. PMID 21374068 DOI: 10.1007/s00198-011-1587-0  1
2010 Dowsett SA, Van Campen LE, Bednar LA. Developing good scientific publishing practices: one pharmaceutical company's perspective. Current Medical Research and Opinion. 26: 1249-54. PMID 20350148 DOI: 10.1185/03007991003748880  1
2010 Downs RW, Moffett AM, Ghosh A, Cox DA, Dowsett SA, Harper K. Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass Osteoporosis International. 21: 1215-1226. PMID 19798460 DOI: 10.1007/s00198-009-1060-5  1
2010 Mayer MH, Dowsett SA, Brahmavar K, Hornbuckle K, Brookfield WP. Reporting adverse drug events U.S. Pharmacist. 35.  1
2009 Wahaidi VY, Dowsett SA, Eckert GJ, Kowolik MJ. Neutrophil response to dental plaque by gender and race. Journal of Dental Research. 88: 709-14. PMID 19734456 DOI: 10.1177/0022034509339019  1
2009 Collins P, Mosca L, Geiger MJ, Grady D, Kornitzer M, Amewou-Atisso MG, Effron MB, Dowsett SA, Barrett-Connor E, Wenger NK. Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation. 119: 922-30. PMID 19204301 DOI: 10.1161/CIRCULATIONAHA.108.817577  1
2009 Goldstein SR, Duvernoy CS, Calaf J, Adachi JD, Mershon JL, Dowsett SA, Agnusdei D, Stuenkel CA. Raloxifene use in clinical practice: efficacy and safety. Menopause (New York, N.Y.). 16: 413-21. PMID 19092711 DOI: 10.1097/gme.0b013e3181883dae  1
2009 Mosca L, Grady D, Barrett-Connor E, Collins P, Wenger N, Abramson BL, Paganini-Hill A, Geiger MJ, Dowsett SA, Amewou-Atisso M, Kornitzer M. Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke; a Journal of Cerebral Circulation. 40: 147-55. PMID 18948611 DOI: 10.1161/STROKEAHA.108.518621  1
2008 Donatucci CF, Wong DG, Giuliano F, Glina S, Dowsett SA, Watts S, Sorsaburu S. Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Current Medical Research and Opinion. 24: 3383-92. PMID 19032120 DOI: 10.1185/03007990802498440  1
2008 Burshell AL, Song J, Dowsett SA, Mershon JL, Delmas PD, Secrest RJ, Cauley JA. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis. Current Medical Research and Opinion. 24: 807-13. PMID 18254988 DOI: 10.1185/030079908X273282  1
2007 Mack WJ, Dhungana B, Dowsett SA, Keech CA, Feng M, Li Y, Hodis HN. Carotid artery intima-media thickness after raloxifene treatment. Journal of Women's Health (2002). 16: 370-8. PMID 17439382 DOI: 10.1089/jwh.2006.0014  1
2007 Cauley JA, Song J, Dowsett SA, Mershon JL, Cummings SR. Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors. Breast Cancer Research and Treatment. 102: 181-8. PMID 17028986 DOI: 10.1007/s10549-006-9326-5  1
2007 Stotka JL, Rotelli MD, Dowsett SA, Elsner MW, Holdsworth SM, Pitts PJ, McAvoy DR. A new model for communicating risk information in direct-to-consumer print advertisements Drug Information Journal. 41: 111-127.  1
2006 Lippman ME, Cummings SR, Disch DP, Mershon JL, Dowsett SA, Cauley JA, Martino S. Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 5242-7. PMID 16951244 DOI: 10.1158/1078-0432.CCR-06-0688  1
2006 Khan SM, Blanchard SB, Dowsett SA, Eckert GJ, Kowolik MJ. Periodontal assessment by right- and left-handed examiners: is there a difference? Journal of Periodontology. 77: 1099-103. PMID 16805670 DOI: 10.1902/jop.2006.050185  1
2006 Venekamp WJ, Kerr L, Dowsett SA, Johnson PA, Wimberley D, McKenzie C, Malone J, Milicevic Z. Functionality and acceptability of a new electronic insulin injection pen with a memory feature. Current Medical Research and Opinion. 22: 315-25. PMID 16466603 DOI: 10.1185/030079906X80477  1
2006 Ensrud K, Genazzani AR, Geiger MJ, McNabb M, Dowsett SA, Cox DA, Barrett-Connor E. Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis. The American Journal of Cardiology. 97: 520-7. PMID 16461049 DOI: 10.1016/j.amjcard.2005.09.083  1
2005 Martino S, Disch D, Dowsett SA, Keech CA, Mershon JL. Safety assessment of raloxifene over eight years in a clinical trial setting. Current Medical Research and Opinion. 21: 1441-52. PMID 16197663 DOI: 10.1185/030079905X61839  1
2005 Kowolik MJ, Dowsett SA. Leukocyte response to dental plaque accumulation: a risk factor for heart disease? Archives of Internal Medicine. 165: 1795-6; author reply. PMID 16087832 DOI: 10.1001/archinte.165.15.1795-c  1
2005 Duvernoy CS, Kulkarni PM, Dowsett SA, Keech CA. Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics, and effect of raloxifene. Menopause (New York, N.Y.). 12: 444-52. PMID 16037760 DOI: 10.1097/01.GME.0000151653.02620.89  1
2005 Barber MD, Dowsett SA, Mullen KJ, Viktrup L. The impact of stress urinary incontinence on sexual activity in women. Cleveland Clinic Journal of Medicine. 72: 225-32. PMID 15825801  1
2004 Sporn MB, Dowsett SA, Mershon J, Bryant HU. Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action. Clinical Therapeutics. 26: 830-40. PMID 15262454 DOI: 10.1016/S0149-2918(04)90127-0  1
2004 Blumenthal RS, Baranowski B, Dowsett SA. Cardiovascular effects of raloxifene: the arterial and venous systems. American Heart Journal. 147: 783-9. PMID 15131531 DOI: 10.1016/j.ahj.2003.12.019  1
2003 Owens JD, Dowsett SA, Eckert GJ, Zero DT, Kowolik MJ. Partial-mouth assessment of periodontal disease in an adult population of the United States. Journal of Periodontology. 74: 1206-13. PMID 14514235 DOI: 10.1902/jop.2003.74.8.1206  1
2003 Dowsett SA, Kowolik MJ. Oral Helicobacter pylori: can we stomach it? Critical Reviews in Oral Biology and Medicine : An Official Publication of the American Association of Oral Biologists. 14: 226-33. PMID 12799325 DOI: 10.1177/154411130301400307  1
2002 Dowsett SA, Archila L, Foroud T, Koller D, Eckert GJ, Kowolik MJ. The effect of shared genetic and environmental factors on periodontal disease parameters in untreated adult siblings in Guatemala. Journal of Periodontology. 73: 1160-8. PMID 12416774 DOI: 10.1902/jop.2002.73.10.1160  1
2002 Dowsett SA, Eckert GJ, Kowolik MJ. Comparison of periodontal disease status of adults in two untreated indigenous populations of Guatemala, Central America. Journal of Clinical Periodontology. 29: 784-7. PMID 12390578 DOI: 10.1046/j.0303-6979.2002.00177.x  1
2002 Dowsett SA, Kowolik MJ. Extending scientific horizons in the developing world - the Central American experience. British Dental Journal. 193: 311-5. PMID 12368886 DOI: 10.1038/sj.bdj.4801553  1
2002 Dowsett SA, Eckert GJ, Kowolik MJ. The applicability of half-mouth examination to periodontal disease assessment in untreated adult populations. Journal of Periodontology. 73: 975-81. PMID 12296597 DOI: 10.1902/jop.2002.73.9.975  1
2002 Dowsett SA, Kowolik MJ, Archila LA, Eckert GJ, LeBlanc DJ. Subgingival microbiota of indigenous Indians of Central America. Journal of Clinical Periodontology. 29: 159-67. PMID 11895544 DOI: 10.1034/j.1600-051x.2002.290211.x  1
2001 Dowsett SA, Archila L, Kowolik MJ. Oral health status of an indigenous adult population of Central America. Community Dental Health. 18: 162-6. PMID 11580092  1
2001 Dowsett SA, Archila L, Segreto VA, Eckert GJ, Kowolik MJ. Periodontal disease status of an indigenous population of Guatemala, Central America. Journal of Clinical Periodontology. 28: 663-71. PMID 11422588  1
2001 Kowolik MJ, Dowsett SA, Rodriguez J, De La Rosa RM, Eckert GJ. Systemic neutrophil response resulting from dental plaque accumulation. Journal of Periodontology. 72: 146-51. PMID 11288786 DOI: 10.1902/jop.2001.72.2.146  1
1999 Dowsett SA, Archila L, Segreto VA, Gonzalez CR, Silva A, Vastola KA, Bartizek RD, Kowolik MJ. Helicobacter pylori infection in indigenous families of Central America: serostatus and oral and fingernail carriage. Journal of Clinical Microbiology. 37: 2456-60. PMID 10405384  1
1997 Dowsett SA, Hyvönen PM, Kowolik MJ. Functional integrity of human neutrophils following 24 hour incubation with hydroxyapatite and fluoride. Journal of Bioluminescence and Chemiluminescence. 12: 215-21. PMID 9481609 DOI: 10.1002/(SICI)1099-1271(199707/08)12:4<215::AID-BIO447>3.0.CO;2-4  1
Show low-probability matches.